MA27960A1 - Melanges lipidiques synthetiques ameliores pour la preparation d'un tensioactif reconstitue. - Google Patents

Melanges lipidiques synthetiques ameliores pour la preparation d'un tensioactif reconstitue.

Info

Publication number
MA27960A1
MA27960A1 MA27946A MA27946A MA27960A1 MA 27960 A1 MA27960 A1 MA 27960A1 MA 27946 A MA27946 A MA 27946A MA 27946 A MA27946 A MA 27946A MA 27960 A1 MA27960 A1 MA 27960A1
Authority
MA
Morocco
Prior art keywords
preparation
synthetic lipid
lipid mixtures
improved synthetic
reconstituted surfactant
Prior art date
Application number
MA27946A
Other languages
English (en)
Inventor
Tore Curstedt
Jan Johansson
Bengt Robertson
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MA27960A1 publication Critical patent/MA27960A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

L'invention concerne des tensioactifs reconstitués comprenant des phospholipides et des lipides artificiels améliorés capables d'abaisser la tension superficielle à l'interface air-liquide, plus particulièrement des tensioactifs reconstitués comprenant des mélanges phospolipidiques spéciaux et des peptides artificiels qui sont des analogues de la protéine naturelle SP-C. Ces tensioactifs sont destinés au traitement du syndrome respiratoire aigu sévère (SRAS) et autres pathologies associées à des dysfonctionnements de tensioactifs pulmonaires.
MA27946A 2002-05-17 2004-11-16 Melanges lipidiques synthetiques ameliores pour la preparation d'un tensioactif reconstitue. MA27960A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI001058A ITMI20021058A1 (it) 2002-05-17 2002-05-17 Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito

Publications (1)

Publication Number Publication Date
MA27960A1 true MA27960A1 (fr) 2006-07-03

Family

ID=11449919

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27946A MA27960A1 (fr) 2002-05-17 2004-11-16 Melanges lipidiques synthetiques ameliores pour la preparation d'un tensioactif reconstitue.

Country Status (27)

Country Link
US (2) US7511011B2 (fr)
EP (1) EP1506234B1 (fr)
JP (1) JP4883906B2 (fr)
KR (1) KR101028927B1 (fr)
CN (1) CN100347193C (fr)
AT (1) ATE353919T1 (fr)
AU (1) AU2003233320B2 (fr)
CA (1) CA2486152C (fr)
CY (1) CY1106667T1 (fr)
DE (1) DE60311798T2 (fr)
DK (1) DK1506234T3 (fr)
EA (1) EA007928B1 (fr)
ES (1) ES2282627T3 (fr)
HK (1) HK1079221A1 (fr)
HR (1) HRP20041058B1 (fr)
IL (2) IL165239A0 (fr)
IT (1) ITMI20021058A1 (fr)
MA (1) MA27960A1 (fr)
MX (1) MXPA04011369A (fr)
NZ (1) NZ536606A (fr)
PL (1) PL209649B1 (fr)
PT (1) PT1506234E (fr)
SI (1) SI1506234T1 (fr)
TN (1) TNSN04219A1 (fr)
UA (1) UA79609C2 (fr)
WO (1) WO2003097695A1 (fr)
ZA (1) ZA200409215B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
CN1802159B (zh) 2003-03-24 2013-04-24 阿克西金药品公司 治疗哮喘及其它炎症或免疫性疾病的具有ccr3拮抗活性的2-苯氧基-和2-苯基磺酰胺衍生物
EP1481665A1 (fr) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Nouveaux mélanges lipidiques pour tensioactifs synthétiques
UA76074C2 (en) * 2005-11-09 2006-06-15 O V Palladin Inst Of Biochemis Calmophil, pharmaceutical composition for substitution therapy aimed at recovering malfunctioned surfactant system of lungs
JP5405307B2 (ja) 2006-10-13 2014-02-05 キエージ・フアルマチエウテイチ・エツセ・ピ・ア 改善された性質を有する再構成サーファクタント
WO2008121811A2 (fr) 2007-03-29 2008-10-09 National Jewish Medical And Research Center Lipides tensioactifs, compositions et utilisation de ceux-ci
EP1997502A1 (fr) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Agents tensioactifs reconstitués dotés de propriétés améliorées
EP2022798A1 (fr) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Peptides synthétiques de surfactant pulmonaire
US8287887B2 (en) 2008-04-02 2012-10-16 The University Of Tokushima Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
RU2013112562A (ru) * 2010-08-30 2014-10-10 Ф. Хоффманн-Ля Рош Аг Тетранектин-аполипопротеин а-i, содержащие его липидные частицы и его применение
KR20140054115A (ko) 2011-08-25 2014-05-08 에프. 호프만-라 로슈 아게 단축 테트라넥틴-아포지단백질 a-i 융합 단백질, 그를 함유하는 지질 입자 및 그의 용도
KR102122088B1 (ko) 2012-11-21 2020-06-12 키에시 파르마슈티시 엣스. 피. 에이. 재구성된 폐 계면활성제

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08512056A (ja) * 1993-06-30 1996-12-17 ジェネンテク・インコーポレイテッド リポソームの製造法
WO1997035882A1 (fr) * 1996-03-27 1997-10-02 Ortho Pharmaceutical Corporation Compositions lyophilisees de peptides tensioactifs pulmonaires
IT1308180B1 (it) 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
AU2001245848A1 (en) * 2000-03-15 2001-10-23 Advanced Research And Technology Institute Oral tolerance induction by collagen to prevent allograft rejection
JP2003530356A (ja) 2000-04-12 2003-10-14 アルタナ ファルマ アクチエンゲゼルシャフト 急性肺疾患の予防又は早期治療のための肺表面活性物質の新規使用
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1997502A1 (fr) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Agents tensioactifs reconstitués dotés de propriétés améliorées
EP2022798A1 (fr) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Peptides synthétiques de surfactant pulmonaire

Also Published As

Publication number Publication date
EP1506234A1 (fr) 2005-02-16
PL372751A1 (en) 2005-08-08
HK1079221A1 (en) 2006-03-31
WO2003097695A1 (fr) 2003-11-27
PT1506234E (pt) 2007-05-31
US7842664B2 (en) 2010-11-30
ITMI20021058A0 (it) 2002-05-17
TNSN04219A1 (en) 2007-03-12
NZ536606A (en) 2006-10-27
EA007928B1 (ru) 2007-02-27
CY1106667T1 (el) 2012-05-23
DK1506234T3 (da) 2007-06-11
JP4883906B2 (ja) 2012-02-22
KR101028927B1 (ko) 2011-04-12
AU2003233320A2 (en) 2003-12-02
CN100347193C (zh) 2007-11-07
AU2003233320B2 (en) 2008-06-19
US20050176625A1 (en) 2005-08-11
ITMI20021058A1 (it) 2003-11-17
ES2282627T3 (es) 2007-10-16
DE60311798T2 (de) 2007-10-31
IL165239A (en) 2012-10-31
HRP20041058B1 (hr) 2013-11-22
JP2006504635A (ja) 2006-02-09
ZA200409215B (en) 2006-02-22
KR20050016408A (ko) 2005-02-21
AU2003233320A1 (en) 2003-12-02
US20080242589A1 (en) 2008-10-02
EA200401385A1 (ru) 2005-08-25
UA79609C2 (en) 2007-07-10
CN1653088A (zh) 2005-08-10
CA2486152A1 (fr) 2003-11-27
PL209649B1 (pl) 2011-09-30
CA2486152C (fr) 2012-09-11
HRP20041058A2 (en) 2005-02-28
IL165239A0 (en) 2005-12-18
DE60311798D1 (de) 2007-03-29
MXPA04011369A (es) 2005-02-17
EP1506234B1 (fr) 2007-02-14
ATE353919T1 (de) 2007-03-15
SI1506234T1 (sl) 2007-06-30
US7511011B2 (en) 2009-03-31

Similar Documents

Publication Publication Date Title
HK1079221A1 (en) Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant
WO2002080860A3 (fr) Procedes, composes et compositions pour reduire la masse grasse et moduler le metabolisme des acides gras
CL2004001551A1 (es) Formula para infantes o de continuacion, que comprende una fuente de proteinas, lipidos, carbohidratos y un probiotico, donde al menos 40% de las proteinas son proteinas de suero dulce modificadas que comprenden una cantidad reducida de cgmp o no con
ATE260644T1 (de) Peptid/lipid-komplexbildung durch co- lyophilisation
ATE223436T1 (de) Synthetische pulmonäre oberflächenaktive peptide
ATE486499T1 (de) Angereicherte säuglingsanfangsnahrung
WO2005021579A3 (fr) Peptides mimetiques epo et proteines de fusion
BR0008916A (pt) Composiçao nutricional projetada para maturação gastrointestinal especìfica em mamìferos prematuros
MY134314A (en) Alertness bar
HK1083296A1 (en) Enteral composition for the prevention and/or treatment of sepsis
DK1228708T3 (da) Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk
ATE253927T1 (de) Wirkstoff für verbesserten fettstoffwechsel
EA200501684A1 (ru) Новые липидные смеси для синтетических сурфактантов
UA26313A (uk) Засіб для замісhої терапії захворюваhь дихальhих шляхів, переважhо при сиhдромі задухи
CA99569S (en) Engine shroud
DK1607399T3 (da) Bis-(N,N'-bis-(2-halogenethyl)-amino)-phosphoramidater som antitumormidler
川村欣也 Enhanced hepatic lipid peroxidation in patients with primary biliary cirrhosis
TH127104B (th) สารลดความตึงผิวที่ถูกประกอบขึ้นใหม่โดยมีคุณสมบัติที่ได้รับการปรับปรุงให้ดีขึ้น
ES2161041T3 (es) Preparado de un tensioactivo pulmonar para instilacion y para la aplicacion oral.
TH41167EX (th) อ่างล้างหน้า
CU22479A1 (es) Surfactante pulmonar natural porcino
TH28969S1 (th) เก้าอี้
ATE294623T1 (de) Geduldspiel